Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Roche===Genentech
Entity

Roche===Genentech

Tracked across 1 events · 9 articles · First seen Mar 09, 2026 · Last active Mar 09, 2026

Sentiment
-20
Attention
2
Events
1
Relationships
1
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
2 -20
Business
Genentech's Giredestrant persevERA Study Fails
Roche===Genentech announced that its Phase III persevERA Breast Cancer study for giredestrant did not meet its primary objective, which could negatively impact the company's stock and future revenue from this specific drug. However, they remain confident in giredestrant's potential in other studies.
Mar 09, 2026 · 9 articles
Relationships (1)
Levi Garraway chief medical officer ↔ Roche===Genentech Levi Garraway is the chief medical officer and head of Global Product Developmen
NEWSDESK
Track Roche===Genentech live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.